Available Clinical Trials at UF Health Cancer Center
- June 10, 2016
- No responses
UF Health Cancer Center has several clinical trials in process, below please find information about four trials that are currently accepting participants:
A Phase 1/2, Open-Label Safety and Efficacy Evaluation of CRS-207 in Combination With Epacadostat in Adults With Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer.
A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer.
A Phase 3 Randomized, Open-Label Study Comparing Vaccinia Virus Based Oncolytic Immunotherapy (Pexa Vec, Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy.
NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas
For more information about these or any other clinical trials available at UF Health please visit www.UFHealth.org/navigator, e-mail email@example.com, or call (352) 275-8675.